Fondaparinux
Fondaparinux Brand names, Fondaparinux Analogs
Fondaparinux Brand Names Mixture
- No information avaliable
Fondaparinux Chemical_Formula
C31H43N3Na10O49S8
Fondaparinux RX_link
http://www.rxlist.com/cgi/generic3/arixtra.htm
Fondaparinux fda sheet
Fondaparinux msds (material safety sheet)
Fondaparinux Synthesis Reference
No information avaliable
Fondaparinux Molecular Weight
1726.77 g/mol
Fondaparinux Melting Point
No information avaliable
Fondaparinux H2O Solubility
No information avaliable
Fondaparinux State
Liquid
Fondaparinux LogP
No information avaliable
Fondaparinux Dosage Forms
Solution
Fondaparinux Indication
For the treatment of prophylaxis of deep vein thrombosis.
Fondaparinux Pharmacology
Fondaparinux is a synthetic and specific inhibitor of activated Factor X (Xa) indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism. Fondaparinux is also indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin, and the treatment of acute pulmonary embolism when administered in conjunction with warfarin. Fondaparinux does not inactivate thrombin (activated Factor II) and has no known effect on platelet function. At the recommended dose, Fondaparinux does not affect fibrinolytic activity or bleeding time.
Fondaparinux Absorption
100%
Fondaparinux side effects and Toxicity
No information avaliable
Fondaparinux Patient Information
No information avaliable
Fondaparinux Organisms Affected
Humans and other mammals
